Skip to main content

28 publications

Name Date Type Actions

Monthy information regarding the total number of voting rights and shares making of the share capital - April 2024

As per articles L2338II of « Code de Commerce » and  223.16 of the «Reglement Général de L’Autorité des Marchés Financiers »

06/05/2024 Voting rights

Buyback programs - April 2024

Monthly communication regarding buyback programs

06/05/2024 Liquidity contract

SALES 1st quarter 2024: €134M

The Vetoquinol Group recorded sales of €133.7 million in the 1st quarter of fiscal 2024, including €83.4 million for Essential products.

29/04/2024 Public releases

Availability of the 2023 universal registration document

On 24 April 2024, Vetoquinol filed its 2022 Universal Registration Document with the Autorité des Marchés Financiers (AMF) in ESEF (European Single Electronic Format).

24/04/2024 Public releases

Universal registration document 2023 XBRL version

Universal Registration Document including the Annual Financial Report

24/04/2024 Reference document

Universal registration document 2023

Universal Registration Document including the Annual Financial Report

24/04/2024 Reference document

BALO : Notice of meeting

Shareholders are invited to attend the Combined General Meeting to be held on Tuesday May 28, 2024 at 11 a.m. at the Company's registered office, Magny-Vernois 70 200 LURE, in order to deliberate on the following agenda and draft resolutions

22/04/2024 Shareholders´s Meeting

Monthly information regarding the total number of voting rights – March 2024

As per articles L2338II of « Code de Commerce » and  223.16 of the «Reglement Général de L’Autorité des Marchés Financiers »

04/04/2024 Voting rights

Buyback programs - March 2024

Monthly communication regarding buyback programs

04/04/2024 Description of buyback programs

ANNUAL RESULTS 2023 (slideshow)

01.2023 Highlights
02.2023 Consolidated financial statements
03.Strategy and outlook

20/03/2024 Annual Report

2023 ANNUAL RESULTS

Annual sales: €529m (stable at constant exchange rates)
Essentials sales: €313m (+4.5% at constant exchange rates)
Net income - Group share: €56m (10.5% of sales)
EBITDA: €113m (21.3% of sales)
Free cash-flow: €89m

20/03/2024 Public releases

Monthly information regarding the total number of voting rights – February 2024

As per articles L2338II of « Code de Commerce » and  223.16 of the «Reglement Général de L’Autorité des Marchés Financiers »As per articles L2338II of « Code de Commerce » and  223.16 of the «Reglement Général de L’Autorité des Marchés Financiers »

05/03/2024 Voting rights

Monthly information regarding the total number of voting rights – January 2024

As per articles L2338II of « Code de Commerce » and  223.16 of the «Reglement Général de L’Autorité des Marchés Financiers »

 

02/02/2024 Voting rights

Buyback programs – January 2024

Monthly communication regarding buyback programs

02/02/2024 Description of buyback programs

Annual sales 2023: €529 million

Annual Sales of Essential products: €313 million (up 4.5% at constant exchange rates)

24/01/2024 Public releases

Monthly information regarding the total number of voting rights – December 2023

As per articles L233‐8‐II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers »

04/01/2024 Voting rights

2024 Calendar of financial communication

Vetoquinol published its calendar of financial communication for 2024.

03/01/2024 Agenda

Rapport complémentaire du conseil d'administration sur l'utilisation des délégations de compétence - conseil d'administration du 16 novembre 2006 (french)

22/12/2006

Descriptif du programme de rachat par la société de ses propres actions autorisé par l'assemblée générale mixte des actionnaires du 9 octobre 2006 et mis en œuvre par le conseil d'administration du 8 décembre 2006 (french)

22/12/2006 Description of buyback programs

Mise en place d'un contrat de liquidité (french)

19/12/2006

Annonce de la fin de la période de stabilisation (french)

11/12/2006 Ipo

Exercice intégral de l'option de sur-allocation (french)

11/12/2006 Ipo

Vetoquinol Succes IPO (french)

17/11/2006 Ipo

Visa AMF (french)

06/11/2006 Ipo

Note d'opération n°06-388 (french)

03/11/2006 Ipo

Initial public offering: Eurolist of Euronext Paris

03/11/2006 Ipo

Enregistrement du document de base (french)

23/10/2006 Ipo

Document de base n° I-06.165 (french)

20/10/2006 Ipo